Literature DB >> 25096892

Physiological significance of delayed rectifier K(+) channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease.

Itsuro Kazama1.   

Abstract

T lymphocytes predominantly express delayed rectifier K(+) channels (Kv1.3) in their plasma membranes. More than 30 years ago, patch-clamp studies revealed that the channels play crucial roles in facilitating the calcium influx necessary to trigger lymphocyte activation and proliferation. In addition to selective channel inhibitors that have been developed, we recently showed physiological evidence that drugs such as nonsteroidal anti-inflammatory drugs, antibiotics, and anti-hypertensives effectively suppress the channel currents in lymphocytes, and thus exert immunosuppressive effects. Using experimental animal models, previous studies revealed the pathological relevance between the expression of ion channels and the progression of renal diseases. As an extension, we recently demonstrated that the overexpression of lymphocyte Kv1.3 channels contributed to the progression of chronic kidney disease (CKD) by promoting cellular proliferation and interstitial fibrosis. Together with our in-vitro results, the studies indicated the therapeutic potency of Kv1.3-channel inhibitors in the treatment or the prevention of CKD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25096892     DOI: 10.1007/s12576-014-0331-x

Source DB:  PubMed          Journal:  J Physiol Sci        ISSN: 1880-6546            Impact factor:   2.781


  117 in total

1.  A voltage-gated K(+) current in renal inner medullary collecting duct cells.

Authors:  Laura I Escobar; Julio C Martínez-Téllez; Monica Salas; Salvador A Castilla; Rolando Carrisoza; Dagoberto Tapia; Mario Vázquez; José Bargas; Juan J Bolívar
Journal:  Am J Physiol Cell Physiol       Date:  2003-12-18       Impact factor: 4.249

2.  Effects of kinase inhibitors on TGF-beta induced upregulation of Kv1.3 K+ channels in brain macrophages.

Authors:  Tom Schilling; Claudia Eder
Journal:  Pflugers Arch       Date:  2003-09-05       Impact factor: 3.657

3.  Voltage-dependent biphasic effects of chloroquine on delayed rectifier K(+)-channel currents in murine thymocytes.

Authors:  I Kazama; Y Maruyama; Y Murata; M Sano
Journal:  J Physiol Sci       Date:  2012-02-12       Impact factor: 2.781

4.  Experimentally induced chronic renal insufficiency in the rat.

Authors:  A B MORRISON
Journal:  Lab Invest       Date:  1962-04       Impact factor: 5.662

5.  A voltage-gated potassium channel in human T lymphocytes.

Authors:  M D Cahalan; K G Chandy; T E DeCoursey; S Gupta
Journal:  J Physiol       Date:  1985-01       Impact factor: 5.182

6.  Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels.

Authors:  Ivica Grgic; Eva Kiss; Brajesh P Kaistha; Christoph Busch; Michael Kloss; Julia Sautter; Anja Müller; Anuradha Kaistha; Claudia Schmidt; Girija Raman; Heike Wulff; Frank Strutz; Hermann-Josef Gröne; Ralf Köhler; Joachim Hoyer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-13       Impact factor: 11.205

7.  Calcium antagonistic effects and the in vitro duration of actions of KW-3049, a new 1,4-dihydropyridine derivative, in isolated canine coronary arteries.

Authors:  A Karasawa; K Kubo
Journal:  Jpn J Pharmacol       Date:  1988-05

8.  Chronic uremia syndrome in dogs induced with uranyl nitrate.

Authors:  S Fukuda; J D Kopple
Journal:  Nephron       Date:  1980       Impact factor: 2.847

9.  Molecular basis for the inhibition of 1,4-dihydropyridine calcium channel drugs binding to their receptors by a nonspecific site interaction mechanism.

Authors:  H S Young; V Skita; R P Mason; L G Herbette
Journal:  Biophys J       Date:  1992-05       Impact factor: 4.033

10.  Kv1.3 inhibitors have differential effects on glucose uptake and AMPK activity in skeletal muscle cell lines and mouse ex vivo skeletal muscle.

Authors:  D Lee Hamilton; Craig Beall; Stewart Jeromson; Cyrille Chevtzoff; Daniel J Cuthbertson; Michael L J Ashford
Journal:  J Physiol Sci       Date:  2013-09-17       Impact factor: 2.781

View more
  10 in total

1.  Effect of lysophosphatidic acid on the immune inflammatory response and the connexin 43 protein in myocardial infarction.

Authors:  Duoduo Zhang; Yan Zhang; Chunyan Zhao; Wenjie Zhang; Guoguang Shao; Hong Zhang
Journal:  Exp Ther Med       Date:  2016-03-09       Impact factor: 2.447

2.  Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases.

Authors:  Itsuro Kazama; Tsutomu Tamada; Masahiro Tachi
Journal:  Inflamm Res       Date:  2015-07-24       Impact factor: 4.575

3.  Margatoxin-bound quantum dots as a novel inhibitor of the voltage-gated ion channel Kv1.3.

Authors:  Austin B Schwartz; Anshika Kapur; Wentao Wang; Zhenbo Huang; Erminia Fardone; Goutam Palui; Hedi Mattoussi; Debra Ann Fadool
Journal:  J Neurochem       Date:  2016-12-12       Impact factor: 5.372

Review 4.  Roles of lymphocyte kv1.3-channels in the pathogenesis of renal diseases and novel therapeutic implications of targeting the channels.

Authors:  Itsuro Kazama
Journal:  Mediators Inflamm       Date:  2015-03-18       Impact factor: 4.711

5.  Nonsteroidal Anti-Inflammatory Drugs Quickly Resolve Symptoms Associated with EBV-Induced Infectious Mononucleosis in Patients with Atopic Predispositions.

Authors:  Itsuro Kazama; Chieko Miura; Toshiyuki Nakajima
Journal:  Am J Case Rep       Date:  2016-02-14

6.  Second-Generation Histamine H1 Receptor Antagonists Suppress Delayed Rectifier K+-Channel Currents in Murine Thymocytes.

Authors:  Kazutomo Saito; Nozomu Abe; Hiroaki Toyama; Yutaka Ejima; Masanori Yamauchi; Hajime Mushiake; Itsuro Kazama
Journal:  Biomed Res Int       Date:  2019-04-30       Impact factor: 3.411

Review 7.  Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond.

Authors:  Xiaoli Wang; Guoyi Li; Jingkang Guo; Zhiping Zhang; Shuzhang Zhang; Yudan Zhu; Jiwei Cheng; Lu Yu; Yonghua Ji; Jie Tao
Journal:  Front Neurosci       Date:  2020-01-14       Impact factor: 4.677

Review 8.  Lymphocyte Kv1.3-channels in the pathogenesis of chronic obstructive pulmonary disease: novel therapeutic implications of targeting the channels by commonly used drugs.

Authors:  Itsuro Kazama; Tsutomu Tamada
Journal:  Allergy Asthma Clin Immunol       Date:  2016-11-29       Impact factor: 3.406

9.  Delayed Rectifier K+-Channel Is a Novel Therapeutic Target for Interstitial Renal Fibrosis in Rats with Unilateral Ureteral Obstruction.

Authors:  Nozomu Abe; Hiroaki Toyama; Kazutomo Saito; Yutaka Ejima; Masanori Yamauchi; Hajime Mushiake; Itsuro Kazama
Journal:  Biomed Res Int       Date:  2019-11-07       Impact factor: 3.411

10.  Kv1.3 Channel Inhibition Limits Uremia-Induced Calcification in Mouse and Human Vascular Smooth Muscle.

Authors:  Violeta Cazaña-Pérez; Pilar Cidad; Juan F Navarro-González; Jorge Rojo-Mencía; Frederic Jaisser; José R López-López; Diego Alvarez de la Rosa; Teresa Giraldez; Maria Teresa Pérez-García
Journal:  Function (Oxf)       Date:  2020-12-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.